We are pleased to make available a recording of our recent webinar, “The truth about telemedicine, HCP engagement and evolving practice dynamics: A data-based view of emerging trends during the time of COVID-19.”
View our insights-led exploration of COVID-driven changes occurring in HCPs’ prescribing decisions, virtual patient visits and rep e-details. Understanding the specific reasons for these behavioral changes will help your team move towards restart, as we begin to reopen across the country post-COVID.
View the webinar recording and listen as we deliver early insights on the impact of COVID-19 on HCP practices and the resulting new era of HCP engagement.
Ipsos’ experts will review the second-wave results of our COVID-19 HCP Surveillance Research with 398 HCPs across nine specialties, conducted together with M360 Research.
Together we will explore how COVID-19 is changing HCPs’ practice dynamics and their interactions with pharmaceutical manufacturers. During this session we will:
- Explore the implications and opportunities for brand planning
- Break down potential barriers to your field force strategy
- Help you assess appropriate action, when adapting to this new normal
Glean insights from Ipsos’ data and the discussion with our experts during our interactive audience Q&A, by watching the recording!
To take you further along on your journey, we would be delighted discuss the details of the research, as well as how we can help your team reflect on the impacts of COVID-19 and reframe your plans:
[WEBINAR] Medical Devices & Diagnostics: Current view of the entire ecosystem
We invite you to join Ipsos’ Medtech experts to explore the impact of COVID-19 across the entire medical devices & diagnostics ecosystem. Learn how labs, surgeons, payers and hospital administrators are being affected and take a look at what lies ahead for manufacturers.